Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 13 Taishogun Nishitakatsukasa-Cho, Kita-ku, Kyoto 403-8334, Japan.
J Med Chem. 2012 Nov 26;55(22):9562-75. doi: 10.1021/jm300837y. Epub 2012 Nov 12.
To find HDAC8-selective inhibitors, we designed a library of HDAC inhibitor candidates, each containing a zinc-binding group that coordinates with the active-site zinc ion, linked via a triazole moiety to a capping structure that interacts with residues on the rim of the active site. These compounds were synthesized by using click chemistry. Screening identified HDAC8-selective inhibitors including C149 (IC(50) = 0.070 μM), which was more potent than PCI-34058 (6) (IC(50) = 0.31 μM), a known HDAC8 inhibitor. Molecular modeling suggested that the phenylthiomethyl group of C149 binds to a unique hydrophobic pocket of HDAC8, and the orientation of the phenylthiomethyl and hydroxamate moieties (fixed by the triazole moiety) is important for the potency and selectivity. The inhibitors caused selective acetylation of cohesin in cells and exerted growth-inhibitory effects on T-cell lymphoma and neuroblastoma cells (GI(50) = 3-80 μM). These findings suggest that HDAC8-selective inhibitors have potential as anticancer agents.
为了寻找 HDAC8 选择性抑制剂,我们设计了一组 HDAC 抑制剂候选物,每个候选物都含有一个与活性位点锌离子配位的锌结合基团,通过三唑部分与帽结构相连,帽结构与活性位点边缘的残基相互作用。这些化合物是通过点击化学合成的。筛选鉴定出包括 C149(IC50=0.070μM)在内的 HDAC8 选择性抑制剂,其活性强于已知的 HDAC8 抑制剂 PCI-34058(6)(IC50=0.31μM)。分子模拟表明,C149 的苯硫甲基基团与 HDAC8 的独特疏水口袋结合,苯硫甲基和羟肟酸基团的取向(由三唑部分固定)对活性和选择性很重要。抑制剂在细胞中引起黏连蛋白的选择性乙酰化,并对 T 细胞淋巴瘤和神经母细胞瘤细胞产生生长抑制作用(GI50=3-80μM)。这些发现表明 HDAC8 选择性抑制剂具有作为抗癌药物的潜力。